E. I. Ryabova

Single-Domain Antibodies Efficiently Neutralize SARS-CoV-2 Variants of Concern

I. A. FAVORSKAYA, Dmitry V. Shcheblyakov, I. B. Esmagambetov et al. · Frontiers in Immunology · 2022 · 35 citations · Full text

Heterodimeric Molecule, Single-domain Antibodies, Vaccine Target +12

Nanobodies Are Potential Therapeutic Agents for the Ebola Virus Infection

I. B. Esmagambetov, Dmitry V. Shcheblyakov, Daria A. Egorova et al. · Acta Naturae · 2021 · 19 citations · Full text

Nanoparticles, Engineering, Immunology +18

rAAV expressing recombinant neutralizing antibody for the botulinum neurotoxin type A prophylaxis

Artem A. Derkaev, E. I. Ryabova, I. B. Esmagambetov et al. · Frontiers in Microbiology · 2022 · 10 citations · Full text

rAAV expressing recombinant antibody for emergency prevention and long-term prophylaxis of COVID-19

I. B. Esmagambetov, E. I. Ryabova, Artem A. Derkaev et al. · Frontiers in Immunology · 2023 · 10 citations · Full text